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Rodent studies have recently demonstrated substantial integration of transplanted photoreceptors, with potential
synaptic connection and functional restoration. Consequently, photoreceptor transplantation therapy for retinitis
pigmentosa is attracting a growing interest in the field of translational research. Differentiation strategies for the
formation of three-dimensional (3D) retinal tissue that are suitable for graft preparation have also been introduced
via the use of human embryonic stem cells (hESCs) and human induced pluripotent stem cells. We have recently
shown that hESC-derived retinal tissue (hESC-retina) can survive, mature, and potentially integrate with host
secondary neurons following transplantation into two established primate models of retinal degeneration. Our data
demonstrated the feasibility of deploying hESC-retina transplantation as a new remedy with which to restore the
vision of patients with end-stage retinal degenerative diseases. In the present mini-review, we provide a short
introduction of photoreceptor transplantation research.
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The retina is composed of three layers of neurons, with
photoreceptor cells located in the outermost layer. There
are two types of photoreceptors, rods and cones, which
respond to light and transfer signals to the inner
neurons (Fig. 1a). Retinitis pigmentosa (RP) is a genetic
disease characterized by the progressive loss of rod
photoreceptors followed by secondary degeneration of
cone photoreceptors, with more than 45 causal genes
reported to date [1, 2]. However, only a limited number of
effective treatments are currently available for this disease.
Recently, photoreceptor transplantation therapy has been
attracting increasing interest in the field of translational
research for patients with RP (Fig. 1b). This interest stems
from the first clinical trial using human retinal pigment
epithelium derived from human induced pluripotent stem* Correspondence: hiroshi1895r@cdb.riken.jp
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the Creative Commons license, and indicate ifcells (hiPSCs), which was transplanted into the eye of a
patient with advanced age-related macular degeneration
[3]. Rodent studies have also demonstrated the integration
of transplanted photoreceptors with potential synaptic
connection and functional restoration [4–8]. Important
progress has also been made in the differentiation of
retinal tissue that is of an appropriate quality for grafts.
Eiraku et al. developed a three-dimensional (3D) retina
from mouse embryonic stem cell (ESC) aggregates using
serum-free floating culture of embryoid body-like aggre-
gates with quick reaggregation (referred to as SFEBq
culture) [9]. When floating aggregates of ESCs were
cultured, they spontaneously formed hemispherical vesi-
cles that developed into the optic cup and subsequently
differentiated into the outer (retinal pigment epithelium)
and inner layers of the retina (neural retina). Neural retinas
were then observed to grow into a stratified neural retinal
tissue comprising six types of neural retinal cells. More-
over, self-organizing optic cups and 3D neural retinas have
been successfully created by 3D differentiation culture
from both human ESCs (hESCs) [10, 11] and hiPSCs [12],article is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and























Fig. 1 Schematic image of the human eye and therapeutic scheme of retinal transplantation. a Anatomical structure of the human eye and
retina, which has three layers of neurons. Photoreceptor cells respond to light and are composed of rods and cones, which contain inner
segments (ISs) and outer segments (OSs). b Retinal transplantation scheme. Retinitis pigmentosa (RP) is a group of diseases that cause progressive
photoreceptor degeneration. It is hoped that retinal tissue differentiated from human ES/iPS cells could be transplanted into RP patients with a
degenerative retina without photoreceptors. Although a transplanted retina contains more or less of INL components, the structured layers of
photoreceptors will be in direct contact with the INL of the host retina where graft INLs had been stripped off from graft ONLs
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opmental stage, in any desirable form, and in quantities
that are practical. In this mini-review, we briefly describe
the current status of photoreceptor transplantation.
Photoreceptor transplantation in rodent studies
Over the last decade, a number of studies in rodents
have led to substantial progress being made in photo-
receptor transplantation. MacLaren et al. showed that
during late ontogenetic stages, photoreceptor precursors
can integrate, differentiate into rod photoreceptors, form
synaptic connections, and improve visual function upon
transplantation into wild-type mice and mice models of
early RP [4]. Subsequently, Pearson et al. demonstrated
that transplanted rod-precursor cells restored vision in a
murine model of congenital stationary night blindness
which is devoid of rod function [6]. However, these stud-
ies were conducted with host retinas that retained the
outer nuclear layer (ONL); thus, little was gained in
terms of our understanding of the potential effects of
transplantation in a mouse model of late-stage RP (rd1)
or ONL-depleted host retinas. To solve this issue, we
transplanted retinal tissue derived from murine ESCs
or iPSCs into rd1 mice and subsequently demonstrated
the efficacy of transplantation [8]. Transplanted retinal
tissue developed a structured ONL with mature outer
segments (OSs) and more or less of inner nuclear layer
(INL) components. In some places, graft INL components
were stripped off from structured graft layers of photore-
ceptors (ONL), and the uncovered photoreceptors in the
grafts were revealed to be in direct 3D contact with the
INL of the host retina (Fig. 1b). Detailed immunohisto-
chemical analysis of the host-graft interface revealed adirect contact pattern indicating the successful for-
mation of synaptic connections between graft photo-
receptors and host bipolar cells, which are secondary
neurons and a vital component of the INL. Collectively,
these findings provide us with great hope for the future
treatment of RP.
Transplantation of hESC-derived retinal tissue into
primate models of retinal degeneration
Although the efficacy of retinal tissue transplantation
has been demonstrated in rodent studies, it has until re-
cently remained unclear whether similar results can be
achieved in primate models and human tissue grafts in
terms of host acceptability and graft competency. We
have recently evaluated this issue in a step by step man-
ner [13]. We firstly demonstrated the ability of hESC-
derived retinal tissue (hESC-retina) to survive and fully
mature to form a structured ONL with inner segments
(ISs) and highly specified OSs following transplantation
into nude rats. Direct integration of graft photoreceptors
with host bipolar cells was observed following the trans-
plantation of graft retinas into the subretinal space of an
immunodeficient rat model with end-stage retinal de-
generation. We then developed two novel primate
models of retinal degeneration via the subretinal injec-
tion of cobalt chloride or via 577-nm optically pumped
semiconductor laser photocoagulation. We then evalu-
ated the utility of these primate models of retinal degen-
eration for xenograft experiments by transplanting
hESC-retina into these models. Our studies successfully
demonstrated that grafts could survive and mature to
form a structured ONL and potentially integrate with
host bipolar cells in the eyes of our primate models. In
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identical in terms of post-transplantation survival and
maturation. We are currently evaluating the hiPSC-
derived retina in terms of graft competency. This study
provides evidence of the clinical competency of the hESC-
retina and has revealed novel tools for the optimization of
transplantation strategies for future clinical applications.
Conclusions
In this mini-review, we provide a brief introduction
of the current status of photoreceptor transplantation.
Further research is now required to investigate whether
hESC-derived retinal grafts are indeed functionally in-
tegrated. However, continued progress in this exciting
discipline would finally make it possible for us to restore
vision in RP patients by transplanting retinal tissue.
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